John L. Trotter - Concepedia

Author

John L. Trotter

Washington University in St. Louis

Also Known As

J L Trotter, J Trotter, J. L. Trotter, J. Trotter, J.L. Trotter, JOHN L. TROTTER, John L Trotter, John L. Trotter

Publications

4.5K

Citations

H-Index

107

Concepts

All Affiliations

Washington University in St. Louis National Institutes of Health St. Louis Children's Hospital Neurological Surgery National Institute of Neurological Disorders and Stroke

About

John L. Trotter is an author at Washington University in St. Louis specializing in medicine, neuroimmunology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	39	2.7K
2	Allergy	9	9	581
3	Social Sciences	6	6	296
4	Health Sciences	3	3	142
5	Biochemistry	3	3	141

John L. Trotter

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. Anne H. Cross, Thomas P. Misko, R F Lin, Journal of Clinical Investigation Prime ModelNeurological DisorderNitric OxideImmunologyNitric Oxide Production	1994	383
Lines of Murine Oligodendroglial Precursor Cells Immortalized by an Activated <i>neu</i> Tyrosine Kinase Show Distinct Degrees of Interaction with Axons <i>In Vitro</i> and <i>In Vivo</i> Martin Jung, Martina Grzenkowski, Kit S Tang, European Journal of Neuroscience	1995	267
Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. Amy E. Lovett‐Racke, John L. Trotter, Jörg Lauber, Journal of Clinical Investigation T-regulatory CellImmunologyCd4 T Cell ResponsesT CellsImmunotherapy	1998	264
Pain in Multiple Sclerosis David B. Clifford, John L. Trotter Archives of Neurology	1984	190
Cerebellar Degeneration With Hodgkin Disease John L. Trotter Archives of Neurology Neurological DisorderCorticobasal DegenerationImmunologyPathology21-Year-old Woman	1976	180
Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin‐associated glycoprotein Alan Pestronk, F. Li, John H. Griffin, Neurology Neurological DisorderImmunologySerum AntibodiesPathologyCommon Neurological Disorders	1991	166
Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. Anne H. Cross, Tanya Girard, K S Giacoletto, Journal of Clinical Investigation	1995	156
Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. Mark Kennedy, Litjen Tan, M. C. Dal Canto, The Journal of Immunology Immune ToleranceImmunologyImmune RegulationPathologyPurified Plp	1990	140
Oligoclonal Band Number as a Marker for Prognosis in Multiple Sclerosis Jagannadha Avasarala, Anne H. Cross, John L. Trotter Archives of Neurology Disease ProgressionNeurological DisorderImmunologyDiagnosisPathology	2001	127
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease Stephen D. Miller, S J Gerety, Mary K. Kennedy, Journal of Neuroimmunology MedicineT-regulatory CellImmunologyAntiviral ResponseMurine Encephalomyelitis Virus	1990	114

Page 1